Bowel cancer news
Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the NCRI Cancer Conference.
Men with a high genetic risk of bowel cancer over the next 25 years could have a lower risk of developing the disease if they also have a healthy lifestyle.
Around one in five bowel cancer patients diagnosed after an emergency presentation have displayed at least one cancer ‘alarm symptom’ leading up to diagnosis.
A molecule produced from vitamin A may help protect against some cases of bowel cancer.
An experimental DNA test could help predict which early-stage bowel cancer patients are at a greater risk of their disease returning following surgery.